Reverse phase-HPLC and HPTLC methods for determination of gemifloxacin mesylate in human plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 877, Issue 29, 2009, Pages 3719-3723

  Rote, A R ^a   Pingle, S P ^a  

^a UNIVERSITY OF PUNE   (India)

Author keywords

Gemifloxacin mesylate; HPTLC; Human plasma; Liquid liquid extraction; RP HPLC

Indexed keywords

AT-WAVELENGTH; CALIBRATION CURVES; CHROMATOGRAPHIC METHODS; CONCENTRATION RANGES; DENSITOMETRIC ANALYSIS; ETHYL ACETATES; FREEZE-THAW CYCLES; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN PLASMAS; INTERNAL STANDARDS; ISOCRATIC MODES; MOBILE PHASE; PLASMA SAMPLES; REVERSE PHASE; REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RP-HPLC; SODIUM ACETATE;

ACETIC ACID; ACIDS; CALIBRATION; CHLORINE COMPOUNDS; CHROMATOGRAPHIC ANALYSIS; ESTERS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; LIQUIDS; METHANOL; PH EFFECTS; PHOSPHORIC ACID; PLASMA (HUMAN); PLASMAS; SODIUM; SOLVENT EXTRACTION; THIN LAYER CHROMATOGRAPHY;

PLASMA STABILITY;

GEMIFLOXACIN; HYDROCHLOROTHIAZIDE; LINEZOLID;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DETERMINATION; DRUG PURITY; DRUG STABILITY; DRUG STRUCTURE; HUMAN; PLASMA; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION STUDY;

CHEMICAL FRACTIONATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; FLUOROQUINOLONES; HUMANS; NAPHTHYRIDINES; REPRODUCIBILITY OF RESULTS;

EID: 72049114406     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2009.08.013     Document Type: Article

References (14)

1. Vamsi Krishna M., and Sanker D.G. E-J. Chem. 5 3 (2008) 493
2. Doyle E., Fowles S.E., McDonnell D.F., and White S.A. J. Chromatogr. B 746 (2000) 191
3. Lee W., and Youg Hong C. J. Chromatogr. A 879 (2000) 113
4. Cho S.I., Shim J., Kim M.-S., and Kim Y.-K. J. Chromatogr. A 1055 (2004) 241
5. Liu D., Pei Hu, Matsuhima N., Xiaoming L., and Jiang J. J. Chromatogr. B 856 (2007) 190
6. Ramji J.V., Austi N.E., and Boyle G.W. Drug Metab. Dispos. 29 (2001) 435
7. Meng F., Chen X., Zeng Y., and Zhong D. J. Chromatogr. B 819 (2005) 277
8. Boak L.M., Jian L., Roger L.N., and Rayner C.R. Biomed. Chromatogr. 20 (2006) 782
9. Mody V.D., Pandya K.K., Satia C., Modi I.A., and Gandhi T.P. J. Pharm. Biomed. Anal. 16 (1998) 1289
10. Gan S.H., and Ismail R. J. Chromatogr. B 759 (2001) 325
11. Dagdar D., Burnett P.E., and Gerry M. J. Pharm. Biomed. Anal. 13 (1995) 89
12. Aravindaraj Joghee Rajua, Gopinath Rama, Rajan Sekara, Mahesh Kumar Siddaiahb, Nanjan Moola Jogheeb, and Suresh Bhojrajc. Iranian J. Pharm. Sci. 3 3 (2007) 161
13. US Department of Health and Human Services. FDA Guidance for Industry: Bioanalytical Method validation (2001), US Department of Health and Human Services, Rockville, MD
14. Bansal S., and DeStefano A. AAPS J. 9 1 (2007) E109